Optimizing triple therapy in patients with metastatic hormone-sensitive prostate cancer.
- DOI
- 10.1016/j.acuroe.2024.10.005
- Published
- 2024-10-30
- Container
- Actas Urol Esp (Engl Ed)
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.acuroe.2024.10.005,
title = {Optimizing triple therapy in patients with metastatic hormone-sensitive prostate cancer.},
author = {Borque-Fernando A and Pérez-Fentes DA and Rodrigo-Aliaga M and Puente-Vázquez J and Gómez-Iturriaga A and Unda M and Calleja-Hernández MA and Cózar-Olmo JM and Álvarez-Ossorio JL.},
year = {2024},
journal = {Actas Urol Esp (Engl Ed)},
doi = {10.1016/j.acuroe.2024.10.005},
url = {https://doi.org/10.1016/j.acuroe.2024.10.005}
}RIS
TY - JOUR TI - Optimizing triple therapy in patients with metastatic hormone-sensitive prostate cancer. AU - Borque-Fernando A AU - Pérez-Fentes DA AU - Rodrigo-Aliaga M AU - Puente-Vázquez J AU - Gómez-Iturriaga A AU - Unda M AU - Calleja-Hernández MA AU - Cózar-Olmo JM AU - Álvarez-Ossorio JL. PY - 2024 JO - Actas Urol Esp (Engl Ed) DO - 10.1016/j.acuroe.2024.10.005 UR - https://doi.org/10.1016/j.acuroe.2024.10.005 ER -
APA
A, B., DA, P., M, R., J, P., A, G., M, U., MA, C., JM, C., & JL., Á. (2024). Optimizing triple therapy in patients with metastatic hormone-sensitive prostate cancer.. Actas Urol Esp (Engl Ed). https://doi.org/10.1016/j.acuroe.2024.10.005
Source records
- europe-pmc · retrieved 2026-09-25T15:40:11.185Z